Head to Head Analysis: Zicix (OTCMKTS:ZICXD) vs. INVO Fertility (NASDAQ:IVF)

INVO Fertility (NASDAQ:IVF) and Zicix (OTCMKTS:ZICXD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Analyst Ratings

This is a summary of current ratings and price targets for INVO Fertility and Zicix, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	1	2.50
Zicix	0	0	0	0	0.00

INVO Fertility currently has a consensus target price of $20.00, suggesting a potential upside of 1,832.37%. Given INVO Fertility’s stronger consensus rating and higher probable upside, analysts clearly believe INVO Fertility is more favorable than Zicix.

Profitability

This table compares INVO Fertility and Zicix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-183.75%	-420.62%	-45.21%
Zicix	N/A	N/A	N/A

Institutional and Insider Ownership

12.0% of INVO Fertility shares are held by institutional investors. 0.4% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares INVO Fertility and Zicix”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$7.22 million	0.33	-$25.13 million	($352.18)	-0.00
Zicix	N/A	N/A	N/A	($100.14)	-0.00

Zicix has lower revenue, but higher earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Zicix, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

INVO Fertility has a beta of 2.32, suggesting that its stock price is 132% more volatile than the S&P 500. Comparatively, Zicix has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500.

Summary

INVO Fertility beats Zicix on 7 of the 12 factors compared between the two stocks.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Zicix

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.